CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$9.32
-1.89%
Mkt Cap $623.21M
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (3 analysts)
$17.67
Range $11.00 – $25.00
Implied Upside
+89.6%
Consensus $17.67 vs current $9.32
NASDAQ·Healthcare·Biotechnology
$9.32
-1.89%
Mkt Cap $623.21M
Buy
6
Hold
0
Sell
0
Price Target (3 analysts)
$17.67
Range $11.00 – $25.00
+89.6%
Consensus $17.67 vs current $9.32